Current role
Biotechnology · Healthcare
CEO, Board Member
2026-01-01–present
Mario Alberto Accardi
Board Member
Centessa Pharmaceuticals plc (CNTA)Equibles does not estimate personal net worth.
Get an email with a short summary when Centessa Pharmaceuticals plc publishes a filing, an earnings call transcript or a press release.
Get CNTA alertsAbout Mario Alberto Accardi
Mario Alberto Accardi is recorded as CEO and Board Member at Centessa Pharmaceuticals plc (CNTA) since January 1, 2026. Centessa Pharmaceuticals plc reported in an 8-K filed June 24, 2026 that Mario Alberto Accardi was terminated as Director, effective June 24, 2026. Centessa Pharmaceuticals plc reported in an 8-K filed June 24, 2026 that Mario Alberto Accardi was terminated as Chief Executive Officer, effective June 24, 2026. Centessa Pharmaceuticals plc reported in an 8-K filed December 11, 2025 that Mario Alberto Accardi was appointed member of the Board of Directors, effective January 1, 2026. Equibles holds 4 filed executive changes naming Mario Alberto Accardi; each is listed under recent activity with its source filing. Centessa Pharmaceuticals plc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Centessa Pharmaceuticals plc includes Francesco De Rubertis (Chairman), John Crowley (CFO), Thomas Templeman (CTO) and 7 others.
“each of Francesco De Rubertis, Mario Alberto Accardi, Arjun Goyal, Mary Lynne Hedley, Mathias Hukkelhoven, Samarth Kulkarni, Carol Stuckley and Brett Zbar ceased serving as a member of the board of directors of Centessa and each committee thereof on which such director served.”
“Mario Alberto Accardi, Ph.D. (Chief Executive Officer and Director), John Crowley, Stephen Kanes, M.D., Ph.D., and Raphael Deferiere ceased to serve in their capacities as executive officers of Centessa.”
Affiliation history
-
Current
2026-01-01–present
-
Current
2026-01-01–present
-
Start not stated–2026-06-24
-
Start not stated–2026-06-24
Company network
Leadership on record at Centessa Pharmaceuticals plc
- Francesco De Rubertis Chairman
- John Crowley CFO
- Thomas Templeman CTO
- Iqbal Hussain General Counsel
- Gregory Weinhoff Chief Accounting Officer
- Gregory Weinhoff, M.D., M.B.A. Chief Accounting Officer
- Raphael Deferiere Chief Accounting Officer
- Raphael Deferiere, CPA Chief Accounting Officer
- Christopher Stokes Board Member
- Kristina Mignon Wright Board Member